South Carolina Medicaid and semaglutide
Wegovy for weight loss: no. Still covered for uses other than obesity, such as heart risk or MASH, which may need a new prior authorization. Ozempic for weight loss: no. Requires a documented type 2 diabetes diagnosis, with metformin and A1c requirements.; for type 2 diabetes South Carolina Medicaid must cover it. Read from South Carolina Department of Health and Human Services documents Nov 6, 2026.
Wegovy · SCDHHS P&T Committee minutes
“GLP-1 medications for obesity would be removed from the PDL 12/31/2025.”
read Nov 6, 2026
Wegovy · SCDHHS P&T Committee minutes
“Wegovy will continue to be covered for indications other than obesity”
read Nov 6, 2026
Ozempic · Prime Therapeutics for SCDHHS
“Trulicity (dulaglutide) and Ozempic (semaglutide) for Diabetes”
read Nov 6, 2026
In 2025 South Carolina Medicaid paid for 45,820 semaglutide prescriptions (Ozempic, Wegovy, Rybelsus), 70% of its GLP-1 prescriptions and 23rd of the 50 states and DC. It reimbursed $46.8 million before rebates, $1,022 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Ozempic | 35,293 | $33.6 million | $952 |
| Wegovy | 9,911 | $12.7 million | $1,277 |
| Rybelsus | 616 | $580,854 | $943 |
Semaglutide in the states around South Carolina
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| South Carolina | 18 | $39/moWellmedr | 45,820 | Medicaid Wegovy: No |
| Georgia | 18 | $39/moWellmedr | 31,646 | Medicaid Wegovy: Not covered (KFF) |
| North Carolina | 19 | $39/moWellmedr | 363,890 | Medicaid Wegovy: Yes |



